Market Cap ₹125 Cr.
Stock P/E 0.0
P/B 1.9
Current Price ₹116.6
Book Value ₹ 62.5
Face Value 10
52W High ₹134
Dividend Yield 0%
52W Low ₹ 55
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 113 | 135 | 152 | 176 | |
Other Income | 1 | 0 | 1 | 3 | |
Total Income | 114 | 136 | 153 | 179 | |
Total Expenditure | 100 | 121 | 135 | 158 | |
Operating Profit | 14 | 15 | 18 | 21 | |
Interest | 6 | 6 | 7 | 9 | |
Depreciation | 4 | 4 | 5 | 6 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 4 | 5 | 6 | 7 | |
Provision for Tax | 1 | 1 | 2 | 2 | |
Profit After Tax | 3 | 3 | 5 | 5 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 3 | 3 | 5 | 5 | |
Adjusted Earnings Per Share | 3 | 3.4 | 4.6 | 5.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 16% | 16% | 0% | 0% |
Operating Profit CAGR | 17% | 14% | 0% | 0% |
PAT CAGR | 0% | 19% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 10% | 9% | 9% | 9% |
ROCE Average | 11% | 11% | 11% | 11% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 40 | 43 | 47 | 52 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 13 | 20 | 27 | 31 |
Other Non-Current Liabilities | 4 | 5 | 5 | 7 |
Total Current Liabilities | 69 | 67 | 104 | 90 |
Total Liabilities | 125 | 134 | 184 | 180 |
Fixed Assets | 48 | 54 | 63 | 73 |
Other Non-Current Assets | 2 | 3 | 5 | 8 |
Total Current Assets | 75 | 77 | 116 | 99 |
Total Assets | 125 | 134 | 184 | 180 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 1 | 26 |
Cash Flow from Operating Activities | 7 | 7 | 6 | 15 |
Cash Flow from Investing Activities | -6 | -10 | -14 | -19 |
Cash Flow from Financing Activities | -1 | 4 | 33 | -21 |
Net Cash Inflow / Outflow | 0 | 0 | 25 | -25 |
Closing Cash & Cash Equivalent | 1 | 1 | 26 | 1 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 3.05 | 3.38 | 4.63 | 5.18 |
CEPS(Rs) | 6.7 | 7.44 | 9.45 | 10.99 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 40.44 | 43.82 | 48.33 | 53.5 |
Core EBITDA Margin(%) | 11.46 | 10.92 | 11.26 | 10.5 |
EBIT Margin(%) | 9 | 8.26 | 8.56 | 8.9 |
Pre Tax Margin(%) | 3.63 | 3.48 | 4.22 | 4.06 |
PAT Margin (%) | 2.64 | 2.44 | 2.98 | 2.87 |
Cash Profit Margin (%) | 5.81 | 5.37 | 6.08 | 6.09 |
ROA(%) | 2.39 | 2.56 | 2.85 | 2.78 |
ROE(%) | 7.54 | 8.03 | 10.04 | 10.17 |
ROCE(%) | 10.99 | 11.29 | 10.16 | 10.73 |
Receivable days | 69.11 | 57.53 | 65.99 | 64.84 |
Inventory Days | 158.91 | 136.15 | 123.57 | 119.52 |
Payable days | 150.56 | 100.65 | 86.95 | 86.39 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.55 | 0.53 | 0.57 | 0.56 |
EV/Core EBITDA(x) | 4.5 | 4.75 | 4.88 | 4.62 |
Net Sales Growth(%) | 0 | 20.08 | 12.14 | 16.16 |
EBIT Growth(%) | 0 | 10.23 | 16.17 | 20.77 |
PAT Growth(%) | 0 | 10.93 | 36.76 | 11.9 |
EPS Growth(%) | 0 | 10.93 | 36.76 | 11.9 |
Debt/Equity(x) | 1.34 | 1.47 | 2.17 | 1.73 |
Current Ratio(x) | 1.09 | 1.15 | 1.12 | 1.1 |
Quick Ratio(x) | 0.38 | 0.38 | 0.63 | 0.39 |
Interest Cover(x) | 1.68 | 1.73 | 1.97 | 1.84 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Mar 2024 |
---|---|
Promoter | 73.01 |
FII | 0.02 |
DII | 0 |
Public | 26.97 |
Others | 0 |
Total | 100 |
# | Mar 2024 |
---|---|
Promoter | 0.79 |
FII | 0 |
DII | 0 |
Public | 0.29 |
Others | 0 |
Total | 1.08 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About